Detalhe da pesquisa
1.
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.
BMC Cancer
; 20(1): 790, 2020 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32819390
2.
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
Am J Gastroenterol
; 114(12): 1909-1918, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31764091
3.
Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
Int J Cancer
; 138(5): 1139-45, 2016 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26376292
4.
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
ESMO Open
; 7(6): 100611, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36463731
5.
Early detection: the impact of genomics.
Virchows Arch
; 471(2): 165-173, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28573511
6.
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.
Virchows Arch
; 461(3): 231-43, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22825001